Shotsy
For individuals using GLP-1 receptor agonists for weight management or Type 2 Diabetes who prioritize data-driven insights and privacy.
Known forShotsy GLP-1 Tracker
Shotsy GLP-1 TrackerFor individuals using GLP-1 receptor agonists for weight management or Type 2 Diabetes who prioritize data-driven insights and privacy.
Shotsy GLP-1 TrackerEmpowering GLP-1 medication users with data-driven tracking and clinical visualization tools to manage their weight-loss journey.
Target audience
Portfolio
Free 2Last updated
Shotsy GLP-1 Tracker
v3.2.5
2mo ago
Primary focus
Health & Fitness · GLP-1 medication tracking
Scale
indie
Target audience
Individuals using GLP-1 receptor agonists for weight management or Type 2 Diabetes who prioritize data-driven insights and privacy.
Released 12 updates for their single active title in the last 6 months, indicating an intense development and iteration cycle.
2 apps analysed
Analysis in progress
Multi-medication scheduling addresses complex poly-pharmacy needs
Distributed across 20 markets, strongest in Europe.
Based on 1 of 2 apps with localized market data — more coverage rolling in as scans complete · last scanned .
1
Positive apps
0
Neutral / mixed
0
Negative apps
75/100
Avg sentiment score
Massive user base and high release velocity make this the primary generalist threat for weight loss tracking.
Strategic outlook coming soon.
What fed this analysis
Strong clinical focus and high update frequency position it as a reliable alternative for medical-grade tracking.
Dominates the behavioral psychology segment of weight loss, creating a high barrier to entry for simple trackers.
Focuses on the physical activity component of weight loss, serving as a complementary tool for GLP-1 users.
Professional-grade supplement and medication management platform that serves the clinical side of the GLP-1 journey.
Provides advanced biometric analysis that complements the weight loss journey by tracking physiological stress.
Targets specific dietary niches that often intersect with GLP-1 medication users seeking metabolic health.
Aggressive release schedule and AI-first positioning indicate a rapid attempt to capture the automated logging market.
